Carasent ASA (CARA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Carasent ASA (CARA) has a cash flow conversion efficiency ratio of 0.055x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr42.91 Million ≈ $4.62 Million USD) by net assets (Skr780.03 Million ≈ $83.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Carasent ASA (CARA) net asset quality to measure how much of total assets are equity-financed.
Carasent ASA - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Carasent ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check CARA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Carasent ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Carasent ASA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yuan Jen Enterprises Co Ltd
TW:1725
|
0.000x |
|
QINGCI GAMES INC. -00001
F:Z56
|
N/A |
|
Southland Holdings Inc.
NASDAQ:SLND
|
0.067x |
|
Fks Multi Agro Tbk
JK:FISH
|
-0.011x |
|
Victory Supermarket Chain Ltd
TA:VCTR
|
0.046x |
|
Mayfield Group Holdings Ltd
AU:MYG
|
0.339x |
|
Sparebank 1 Nordvest
OL:SNOR
|
-0.029x |
|
Humedix Co Ltd
KQ:200670
|
0.037x |
Annual Cash Flow Conversion Efficiency for Carasent ASA (2002–2025)
The table below shows the annual cash flow conversion efficiency of Carasent ASA from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Carasent ASA.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr808.00 Million ≈ $86.95 Million |
Skr40.44 Million ≈ $4.35 Million |
0.050x | +18.44% |
| 2024-12-31 | Skr892.87 Million ≈ $96.09 Million |
Skr37.73 Million ≈ $4.06 Million |
0.042x | +1003.68% |
| 2023-12-31 | Skr955.41 Million ≈ $102.82 Million |
Skr-4.47 Million ≈ $-480.72K |
-0.005x | -117.06% |
| 2022-12-31 | Skr1.23 Billion ≈ $132.00 Million |
Skr33.61 Million ≈ $3.62 Million |
0.027x | -1.18% |
| 2021-12-31 | Skr1.17 Billion ≈ $126.05 Million |
Skr32.48 Million ≈ $3.50 Million |
0.028x | -40.73% |
| 2020-12-31 | Skr400.98 Million ≈ $43.15 Million |
Skr18.76 Million ≈ $2.02 Million |
0.047x | -64.82% |
| 2019-12-31 | Skr90.58 Million ≈ $9.75 Million |
Skr12.04 Million ≈ $1.30 Million |
0.133x | +13561.46% |
| 2018-12-31 | Skr91.43 Million ≈ $9.84 Million |
Skr89.00K ≈ $9.58K |
0.001x | +100.93% |
| 2017-12-31 | Skr61.27 Million ≈ $6.59 Million |
Skr-6.40 Million ≈ $-689.28K |
-0.105x | +85.59% |
| 2016-12-31 | Skr49.05 Million ≈ $5.28 Million |
Skr-35.59 Million ≈ $-3.83 Million |
-0.726x | -64.32% |
| 2015-12-31 | Skr71.47 Million ≈ $7.69 Million |
Skr-31.56 Million ≈ $-3.40 Million |
-0.442x | -250.18% |
| 2014-12-31 | Skr81.90 Million ≈ $8.81 Million |
Skr24.08 Million ≈ $2.59 Million |
0.294x | +32.26% |
| 2013-12-31 | Skr130.79 Million ≈ $14.08 Million |
Skr29.08 Million ≈ $3.13 Million |
0.222x | -20.92% |
| 2012-12-31 | Skr114.85 Million ≈ $12.36 Million |
Skr32.29 Million ≈ $3.47 Million |
0.281x | +44.66% |
| 2011-12-31 | Skr114.03 Million ≈ $12.27 Million |
Skr22.16 Million ≈ $2.39 Million |
0.194x | +187.88% |
| 2010-12-31 | Skr106.59 Million ≈ $11.47 Million |
Skr7.20 Million ≈ $774.38K |
0.068x | -22.98% |
| 2009-12-31 | Skr121.43 Million ≈ $13.07 Million |
Skr10.64 Million ≈ $1.15 Million |
0.088x | +208.41% |
| 2008-12-31 | Skr144.89 Million ≈ $15.59 Million |
Skr-11.71 Million ≈ $-1.26 Million |
-0.081x | +58.13% |
| 2007-12-31 | Skr120.21 Million ≈ $12.94 Million |
Skr-23.21 Million ≈ $-2.50 Million |
-0.193x | -277.51% |
| 2006-12-31 | Skr184.38 Million ≈ $19.84 Million |
Skr-9.43 Million ≈ $-1.01 Million |
-0.051x | +86.87% |
| 2005-12-31 | Skr70.28 Million ≈ $7.56 Million |
Skr-27.38 Million ≈ $-2.95 Million |
-0.390x | +30.18% |
| 2004-12-31 | Skr51.61 Million ≈ $5.55 Million |
Skr-28.80 Million ≈ $-3.10 Million |
-0.558x | +24.11% |
| 2003-12-31 | Skr42.14 Million ≈ $4.54 Million |
Skr-30.98 Million ≈ $-3.33 Million |
-0.735x | +49.68% |
| 2002-12-31 | Skr53.55 Million ≈ $5.76 Million |
Skr-78.24 Million ≈ $-8.42 Million |
-1.461x | -- |
About Carasent ASA
Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webcur, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient comm… Read more